SYRE vs TSN · $7.60B cap vs P/E 22, rev $54.44B
Spyre Therapeutics Inc. (SYRE) versus Tyson Foods Inc (TSN) — a side-by-side from cached financials, not a winner call.
Spyre Therapeutics Inc. (SYRE) is a biotechnology company listed on NASDAQ.
Tyson Foods Inc (TSN) is a farm products company listed on US.
Latest reported SYRE revenue for 2025-12-31 was $0. Net income was -$155.2M. SYRE currently screens at market cap $7.60B.
Latest reported TSN revenue for 2025-09-27 was $54.44B. Net income was $507.0M. TSN currently screens at market cap $20.43B and trailing P/E 22.3.
SYRE currently screens at market cap $7.60B. TSN currently screens at market cap $20.43B and trailing P/E 22.3.
Not investment advice. Open the SYRE and TSN stock pages for the full models.
Not investment advice.